|網(wǎng)站首頁(yè) |醫(yī)學(xué)考研 |考研院校 |執(zhí)業(yè)醫(yī)師 |執(zhí)業(yè)藥師 |執(zhí)業(yè)護(hù)士 |
 |醫(yī)學(xué)圖片 |在線(xiàn)動(dòng)畫(huà) |視頻下載 |醫(yī)學(xué)E書(shū) |醫(yī)學(xué)軟件 |臨床技能 |
 |醫(yī)學(xué)論壇 |
加入收藏
設(shè)為首頁(yè)
最新更新
...
...
您現(xiàn)在的位置: 醫(yī)學(xué)全在線(xiàn) >> 臨床技能 >> 醫(yī)學(xué)論文 >> 藥學(xué) >> 教程正文
  阿爾茨海默病認(rèn)知功能量表述評(píng)           ★★★ 【字體:
阿爾茨海默病認(rèn)知功能量表述評(píng)
文章來(lái)源:醫(yī)學(xué)全在線(xiàn) 更新時(shí)間:2006-5-29 7:27:30 技能論壇

 2.療效評(píng)價(jià)[19,20]:在乙酰膽堿酯酶抑制劑特可林(tacrine)、velnacrine 、毒扁豆堿(physostigmine)、多奈哌齊(donepezil)和rivastigmine治療輕-中度AD的大樣本、多中心、隨機(jī)、雙盲、安慰劑對(duì)照臨床試驗(yàn)中,療效評(píng)價(jià)均采用MMSE、ADAS-cog分測(cè)驗(yàn)和臨床晤談總體印象量表。Arrieta等[20]總結(jié)1981~1997年公開(kāi)發(fā)表的49篇特可林治療AD的論文,應(yīng)用的評(píng)定工具為:MMSE 16篇,ADAS 4篇,3MS、CASI、AVLT等均有報(bào)道。

    六、幾點(diǎn)說(shuō)明

    1. 上述量表對(duì)于確定癡呆的病因即鑒別診斷方面作用有限。

  2. 從55或60歲開(kāi)始縱向隨訪(fǎng)認(rèn)知功能十分重要,尤其是教育程度比較高的老人。

  3. 認(rèn)知評(píng)定只能作為AD診斷的輔助工具,臨床診斷必須結(jié)合日;顒(dòng)能力量表、非認(rèn)知行為問(wèn)卷、總體嚴(yán)重度量表、照料者負(fù)擔(dān)量表及腦影像學(xué)、電生理學(xué)、生化學(xué)檢查結(jié)果,最后確診依賴(lài)于隨訪(fǎng)和病理檢查。

  4. 軀體狀況不佳、情緒障礙、意識(shí)不清、受試者不配合等都可以影響認(rèn)知檢查結(jié)果。

  5. 時(shí)代在發(fā)展,人口的年齡結(jié)構(gòu)和老人素質(zhì)處在變化之中,對(duì)認(rèn)知功能的認(rèn)識(shí)也在深化,故評(píng)定工具也需要不斷修訂以適應(yīng)新的要求。由于知識(shí)產(chǎn)權(quán)等原因,上述大部分測(cè)驗(yàn)沒(méi)有引進(jìn)。我們介紹這些評(píng)定方法,供國(guó)內(nèi)同道在量表編制與使用時(shí)參考。

  參考文獻(xiàn)
   1,Tierney MC, Szalai JP, Snow WG, et al. Domain specificity of the subtests of the mini-mental state examination. Arch Neurol, 1997,54:713-716.

  2,Stuss DT,Meiran N,Guzman DA,et al. Do long tests yield a more accurate diagnosis of dementia than short tests Arch Neurol, 1996,53:1033-1039.

  3,鄭瞻培. 修改后的長(zhǎng)谷川簡(jiǎn)易智能評(píng)定量表. 國(guó)外醫(yī)學(xué)精神病學(xué)分冊(cè),1993,20: 40-41.

  4,Royall DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry, 1998, 64:588-594.

  5,Solomon PR, Hirschoff A, Kelly B, et al. A 7 minute neurocognitive screening battery: highly sensitive to Alzheimer′s disease. Arch Neurol, 1998, 55:349-355.

  6,Lezak MD. Neuropsychological assessment.2nd ed. New York: Oxford University Press, 1983.578-581.

  7,Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer′s disease. Am J Psychiatry, 1984, 141:1356-1364.

  8,Kiernan RJ, Mueller J, Langston JW, et al. The neurobehavioral cognitive status examination: a quantitative approach to cognitive assessment. Ann Intern Med,1987,107:481-485.

  9,Osmon DC, Smet IC, Winegarden B,et al. Neurobehavioral cognitive status examination: its use with unilateral stroke patients in a rehabilitation setting. Arch Phs Med Rehabil, 1992,73:414-418.

  10,F(xiàn)aust D, Fogel B. The development and initial validation of a sensitive bedside cognitive screening test. J Nerv Ment Dis, 1989, 177:25-31.

  11,Glosser G, Wolfe N, Kliner-Krenzel L, et al. Cross-cultural cognitive examination performance in patients with Parkinson′s disease and Alzheimer′s disease. J Nerv Ment Dis, 1994, 182: 432-436.

  12,Mate-Kole CC, Major A, Lenzer I, et al. Validation of the quick cognitive screening test. Arch Phys Med Rehabil, 1994,75:867-875.

  13,Delis DC. Neuropsychological assessment of learning and memory. In: Boller F, Grafman J, eds. Handbook of Neuropsychology. vol.3. New York: Elsevier Science Publishers B.V. (Biomedical Division), 1989.3-30.

14,Chan AS,Salmon DP,Butters N, et al. Semantic network abnormality predicts rate of cognitive decline in patients with probable Alzheimer′s disease. J Int Neuropsychol Soc, 1995, 1:297-303.

  15,Chan AS,Butters N,Salmon DP. The deterioration of semantic networks in patients with Alzheimer′s disease: a cross-sectional study. Neuropsychologia, 1997, 35:241-248.

  16,Morris JC,Heyman A,Mohs RC,et al. The Consortium to Establish a Registry for Alzheimer′s Disease(CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer′s disease. Neurology, 1989,39:1159-1165.

  17,Almkvist O. Neuropsychological features of early Alzheimer′s disease: preclinical and clinical stages. Acta Neurol Scand, 1996, 165 Suppl: 63-71.

  18,Pasquier F. Early diagnosis of dementia: neuropsychology. J Neurol, 1999,246:5-15.

  19,F(xiàn)rancis PT,Palmer AM,Snape M, et al. The cholinergic hypothesis of Alzhemer′s disease: a review of progress. J Neurol Neurosurg Psychiatry, 1999, 66:137-147.

  20,Arrieta JL, Artalejo FR. Methodology,results and quality of clinical trials of tacrine in the treatment of Alzheimer disease: a systematic review of the literature. Age Aging, 1998,27:161-179.

上一頁(yè)  [1] [2] 

更多信息請(qǐng)?jiān)L問(wèn)醫(yī)學(xué)全在線(xiàn)網(wǎng)站考研頻道
...
教程錄入:凌云    責(zé)任編輯:凌云 
  • 上一篇教程:

  • 下一篇教程:
  • 發(fā)表評(píng)論】【加入收藏】【告訴好友】【打印此文】【關(guān)閉窗口
    最新熱點(diǎn) 最新推薦 相關(guān)文章
    外科手術(shù)基礎(chǔ)概述
    多發(fā)性骨髓瘤并發(fā)腎功能衰竭…
    淺談膠片的潛影形成與顯影
    干擾素治療病理性瘢痕的初步…
    微創(chuàng)閉合穿釘外固定架治療肱…
    舒萊預(yù)防腎移植術(shù)后急性排斥…
    PF方案+HCPT治療惡性胸腔積液…
    外傷性前房積血的護(hù)理干預(yù)
    新輔助放化療在中晚期食管癌…
    改良式腹腔鏡下成人腹股溝疝…
    本站部分內(nèi)容來(lái)自互聯(lián)網(wǎng),如果侵犯了您的版權(quán),請(qǐng)來(lái)信告訴我們,歡迎您提供意見(jiàn)和建議! 站長(zhǎng):凌云 皖I(lǐng)CP備06007007號(hào)